Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2014 · second_quarter · 2A
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act Tax reform proposals related to the Orphan Drug Tax Credit
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Filing targets: Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
Source: Senate LDA
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. H.R. 594/S. 315 (Public Law 113-166), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. H.R. 594/S. 315 (Public Law 113-166), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. H.R. 594/S. 315 (Public Law 113-166), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act Tax reform proposals related to the Orphan Drug Tax Credit
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act Tax reform proposals related to the Orphan Drug Tax Credit
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act Tax reform proposals related to the Orphan Drug Tax Credit
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. H.R. 594/S. 315 (Public Law 113-166), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Newborn Screening Saves Lives Reauthorization Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
ABLE Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Enhanced Access to Medicaid Services Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Enhanced Access to Medicaid Services Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Enhanced Access to Medicaid Services Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Enhanced Access to Medicaid Services Act of 2013
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Creating Hope Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
Creating Hope Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012. H.R. 6163/S. 3461, the National Pediatric Research Network Act of 2012.
Creating Hope Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
ABLE Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
ABLE Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
ABLE Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
ABLE Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
ABLE Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
FAST Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
FAST Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
FAST Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012. H.R. 6163/S. 3461, the National Pediatric Research Network Act of 2012.
FAST Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; S. 606, the Creating Hope Act; the Rare Disease Congressional Caucus; drug approval process and reauthorization of the Prescription Drug User Fee Amendments and Best Pharmaceuticals for Children and the Pediatric Research Equity Acts, including S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act, H.R. 4132, Faster Access to Specialized Treatments Act.
EXPERRT Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
EXPERRT Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012. H.R. 6163/S. 3461, the National Pediatric Research Network Act of 2012.
EXPERRT Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
Food and Drug Administration Reform Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
Food and Drug Administration Reform Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
Food and Drug Administration Reform Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012. H.R. 6163/S. 3461, the National Pediatric Research Network Act of 2012.
National Pediatric Research Network Act of 2012
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012. H.R. 6163/S. 3461, the National Pediatric Research Network Act of 2012.
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
FIMBA
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act; the Rare Disease Congressional Caucus; efforts to develop drugs targeting rare diseases; and reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
ABLE Act of 2011
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
ABLE Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
ABLE Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
Achieving a Better Life Experience Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Achieving a Better Life Experience Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
ABLE Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience Act of 2009 (ABLE Act) (S.493/H.R. 1205)
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, and legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158)
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
Don't Ask, Don't Tell Repeal Act of 2010
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Legislation to reauthorize Small Business Innovation Research Program and the Small Business Technology Transfer Program (H.R. 2965/S. 1233)
Don't Ask, Don't Tell Repeal Act of 2010
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Legislation to reauthorize Small Business Innovation Research Program and the Small Business Technology Transfer Program (H.R. 2965/S. 1233)
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, and legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158)
SMA Treatment Acceleration Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
SBIR/STTR Reauthorization Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Legislation to reauthorize Small Business Innovation Research Program and the Small Business Technology Transfer Program (H.R. 2965/S. 1233)
SBIR/STTR Reauthorization Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Legislation to reauthorize Small Business Innovation Research Program and the Small Business Technology Transfer Program (H.R. 2965/S. 1233)
Achieving a Better Life Experience Act of 2009
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Achieving a Better Life Experience Act of 2009 (ABLE Act) (S.493/H.R. 1205)
Community Living Assistance Services and Supports Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Treatment of complex rehabilitation technology under Medicare competitive bidding program, including H.R. 2231, the Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007.
Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Treatment of complex rehabilitation technology under Medicare competitive bidding program, including H.R. 2231, the Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007, and H.R. 6331 (P.L. 110-275), the Medicare Improvements for Patients and Providers Act of 2008.
Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Treatment of complex rehabilitation technology under Medicare competitive bidding program, including H.R. 2231, the Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007, and H.R. 6331 (P.L. 110-275), the Medicare Improvements for Patients and Providers Act of 2008.
To award a Congressional Gold Medal to Jerry Lewis in recognition of his outstanding service to the Nation.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
To award a Congressional Gold Medal to Jerry Lewis in recognition of his outstanding service to the Nation.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2014 · third_quarter · Q3
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. H.R. 594/S. 315 (Public Law 113-166), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2014 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act Tax reform proposals related to the Orphan Drug Tax Credit
Filing targets: Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2014 · first_quarter · Q1
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act Tax reform proposals related to the Orphan Drug Tax Credit
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Filing targets: Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2013 · fourth_quarter · Q4
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2013 · third_quarter · Q3
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2013 · second_quarter · Q2
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and disaster response. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2013 · first_quarter · 1A
Health care funding provisions, including funding for the National Institutes of Health and the Centers for Disease Control, contained within Public Law 113-6, the Department of Defense, Military Construction and Veterans Affairs, and Full-Year Continuing Appropriations Act, 2013
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2013 · first_quarter · Q1
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
S. 755, legislation to apply the Medicaid primary care payment rate to additional physician providers of primary care services
Health care funding provisions, including funding for the National Institutes of Health and the Centers for Disease Control, contained within Public Law 113-6, the Department of Defense, Military Construction and Veterans Affairs, and Full-Year Continuing Appropriations Act, 2013
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2012 · fourth_quarter · Q4
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Implementation of Public Law 112-144), the Food and Drug Administration Safety and Innovation Act
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2012 · third_quarter · Q3
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012. H.R. 6163/S. 3461, the National Pediatric Research Network Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2012 · second_quarter · 2A
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2012 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus. Provisions contained in S. 3187/H.R. 5651 (which became Public Law 112-144), the Food and Drug Administration Safety and Innovation Act, relating to the drug approval process and including the Best Pharmaceuticals for Children and Pediatric Research Equity Acts; S. 606/H.R. 3059, the Creating Hope Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act; H.R. 4132, Faster Access to Specialized Treatments Act; and H.R. 4156/S. 2281, Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2012 · first_quarter · Q1
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; S. 606, the Creating Hope Act; the Rare Disease Congressional Caucus; drug approval process and reauthorization of the Prescription Drug User Fee Amendments and Best Pharmaceuticals for Children and the Pediatric Research Equity Acts, including S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act, H.R. 4132, Faster Access to Specialized Treatments Act.
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · fourth_quarter · Q4
Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act; the Rare Disease Congressional Caucus; efforts to develop drugs targeting rare diseases; and reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · third_quarter · Q3
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
National Institutes of Health (NIH) funding within the Fiscal Year 2012 Labor-HHS-Education Appropriations Bill (S. 1599)
Federal Aviation Administration policy regarding use of respiratory equipment on commercial airlines
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; S. 606, the Creating Hope Act, the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
Health research funding provisions, including the NIH Cures Acceleration Network of Fiscal Year 2012 Labor-HHS-Education Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2011 · first_quarter · Q1
Health research funding provisions of H.R. 1, the Full Year Continuing Appropriations Act, 2011
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; implementation of Medicare competitive bidding, including H.R. 1041, the Fairness in Medicare Bidding Act; the Rare Disease Congressional Caucus; and efforts to develop drugs targeting rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · fourth_quarter · Q4
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · third_quarter · Q3
H.R. 1205/S. 493, Achieving a Better Life Experience (ABLE) Act of 2009
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; advocating for neurologists' eligibility for Medicare payment incentives under the Patient Protection and Affordable Care Act; research and treatment of spinal muscular atrophy - H.R. 2149/S. 1158; and Competitive Bidding Repeal - H.R. 3790
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2010 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; research and treatment of spinal muscular atrophy -H.R. 2149/S. 1158; and Competitive Bidding Repeal -H.R. 3790
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2009 · third_quarter · Q3
Legislation to reauthorize Small Business Innovation Research Program and the Small Business Technology Transfer Program (H.R. 2965/S. 1233)
Health care reform proposals related to Medicare coverage of power mobility equipment
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158), the Community Living Assistance Services and Supports Act (CLASS Act) (H.R. 1721/S. 697), and H1N1 distribution plans for high priority groups.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2009 · second_quarter · Q2
Health care reform proposals related to Medicare coverage of power mobility equipment
Legislation to reauthorize Small Business Innovation Research Program and the Small Business Technology Transfer Program (H.R. 2965/S. 1233)
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, and legislation to accelerate research and treatment of spinal muscular atrophy (H.R. 2149/S. 1158)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2009 · first_quarter · Q1
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues, rehabilitation research programs, legislation to accelerate research and treatment of spinal muscular atrophy, and clinical comparative effectiveness provisions of H.R. 1, the American Recovery and Reinvestment Act of 2009 (P.L. 111-5).
Funding for the National Institutes for Health for Fiscal Year 2010.
Support for net operating losses provisions contained in H.R. 1, the American Recovery and Reinvestment Act of 2009 (P.L. 111-5).
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · fourth_quarter · Q4
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · third_quarter · Q3
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Treatment of complex rehabilitation technology under Medicare competitive bidding program, including H.R. 2231, the Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007, and H.R. 6331 (P.L. 110-275), the Medicare Improvements for Patients and Providers Act of 2008.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease- H.R. 5265/S. 2618, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008; H.R. 3334/S. 2042, SMA Treatment Acceleration Act; H.R. 493/S. 358 (P.L. 110-233), Genetic Information Nondiscrimination Act; H.R. 2295/S. 1382, the ALS Registry Act.
Treatment of complex rehabilitation technology under Medicare competitive bidding program, including H.R. 2231, the Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007, and H.R. 6331 (P.L. 110-275), the Medicare Improvements for Patients and Providers Act of 2008.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · first_quarter · Q1
Treatment of complex rehabilitation technology under Medicare competitive bidding program, including H.R. 2231, the Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265/S. 2618, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008; H.R. 3334/S. 2042, SMA Treatment Acceleration Act; H.R. 493/S. 358, Genetic Information Nondiscrimination Act; and H.R. 2295/S. 1382, the ALS Registry Act.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · first_quarter · RR
Health care issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 647/S. 313, the Achieving a Better Life Experience (ABLE) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. Rare Disease Congressional Caucus H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Achieving a Better Life Experience Act of 2009 (ABLE Act) (S.493/H.R. 1205)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE